List of works - Steven Gabardi

A Rationale for Age-Adapted Immunosuppression in Organ Transplantation

scientific article

A guide to understanding and implementing risk evaluation and mitigation strategies in organ transplantation

scientific article published on March 2013

A multicenter experience with generic tacrolimus conversion

scientific article

Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus

scientific article published on 18 October 2016

An Update on Risk Evaluation and Mitigation Strategies in Transplantation ⬇️

scientific article published on October 25, 2011

Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximab

scientific article published on 13 January 2010

Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options

scientific article published on 19 April 2014

Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation

scientific article published on May 2015

Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation

scientific article published on 08 April 2012

Belatacept and Long-Term Outcomes in Kidney Transplantation

scientific article published in June 2016

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation

scientific article published on April 2011

Bitter melon (Momordica charantia): a review of efficacy and safety.

scientific article

Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction.

scientific article

Call for antimicrobial stewardship in solid organ transplantation.

scientific article

Comment: management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies

scientific article published on 30 November 2010

Current trends in immunosuppressive therapies for renal transplant recipients

scientific article

Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.

scientific article published on 12 December 2012

Density functional simulations of Sb-rich GeSbTe phase change alloys

scientific article published on 04 September 2012

Dyslipidemia and its therapeutic challenges in renal transplantation

scientific article

Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report

scientific article

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

scientific article

Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis

scientific article

Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial

scientific article published on 30 January 2014

Enteric-coated mycophenolate sodium.

scientific article published on November 2003

Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients

scientific article

Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients

scientific article published on July 2015

Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation

scientific article

Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitors

scientific article published on 17 July 2012

Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology.

scientific article published on October 2010

Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team

scientific article published on 14 June 2011

Future immunosuppressive agents in solid-organ transplantation.

scientific article published in June 2004

Generic immunosuppressants in hematopoietic cell transplantation

scientific article

Generic immunosuppression in transplantation: current evidence and controversial issues

scientific article published on 30 March 2015

Generic maintenance immunosuppression in solid organ transplant recipients

scientific article

Hepatitis B reactivation and rituximab: a new boxed warning and considerations for solid organ transplantation

scientific article published on 4 March 2014

Immunosuppression, generic drugs and the FDA

scientific article published on 17 December 2011

Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia

scientific article

Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates

scientific article published on 01 May 2014

Induction immunosuppressive therapies in renal transplantation

scientific article published on February 2011

Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal

scientific article published on 01 June 2011

Influence of the exchange and correlation functional on the structure of amorphous InSb and In3SbTe2 compounds.

scientific article

Influenza in solid organ transplant recipients.

scientific article

Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns

scientific article

Invasive fungal infections and antifungal therapies in solid organ transplant recipients.

scientific article published on 6 July 2007

Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?

scientific article published on 04 June 2015

Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch

scientific article published on June 2014

Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients

scientific article published on 2 August 2011

Managing Risk in Developing Transplant Immunosuppressive Agents: The New Regulatory Environment ⬇️

scientific article published on 09 August 2011

Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs

scientific article

Micafungin treatment and eradication of candiduria among hospitalized patients

scientific article published on September 2016

Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients

scientific article published on 17 September 2016

Mycophenolate fetal toxicity and risk evaluation and mitigation strategies

scientific article

Nephrotoxicity of Natural Products

scientific article

New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines

article

Pharmacoepidemiology of anemia in kidney transplant recipients

scientific article published in May 2004

Recommendations for the proper use of nonprescription cough suppressants and expectorants in solid-organ transplant recipients

scientific article published on March 2011

Risk evaluation and mitigation strategies: a focus on belatacept

scientific article published on March 2013

Risk evaluation and mitigation strategies: a focus on the mammalian target of rapamycin inhibitors

scientific article published on March 2013

Risk evaluation and mitigation strategies: a focus on the mycophenolic acid preparations

scientific article published on March 2014

Understanding alterations in drug handling with aging: a focus on the pharmacokinetics of maintenance immunosuppressants in the elderly

scientific article published on August 2015

Understanding risk evaluation and mitigation strategies in organ transplantation

scientific article published on July 1, 2011

Use of polyclonal/monoclonal antibody therapies in transplantation

scientific article published on 16 January 2017

List of works by Steven Gabardi

A Rationale for Age-Adapted Immunosuppression in Organ Transplantation

A guide to understanding and implementing risk evaluation and mitigation strategies in organ transplantation

A multicenter experience with generic tacrolimus conversion

Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus

An Update on Risk Evaluation and Mitigation Strategies in Transplantation ⬇️

Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximab

Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options

Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation

Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation

Belatacept and Long-Term Outcomes in Kidney Transplantation

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation

Bitter melon (Momordica charantia): a review of efficacy and safety.

Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction.

Call for antimicrobial stewardship in solid organ transplantation.

Comment: management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies

Current trends in immunosuppressive therapies for renal transplant recipients

Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.

Density functional simulations of Sb-rich GeSbTe phase change alloys

Dyslipidemia and its therapeutic challenges in renal transplantation

Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis

Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial

Enteric-coated mycophenolate sodium.

Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients

Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients

Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation

Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitors

Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology.

Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team

Future immunosuppressive agents in solid-organ transplantation.

Generic immunosuppressants in hematopoietic cell transplantation

Generic immunosuppression in transplantation: current evidence and controversial issues

Generic maintenance immunosuppression in solid organ transplant recipients

Hepatitis B reactivation and rituximab: a new boxed warning and considerations for solid organ transplantation

Immunosuppression, generic drugs and the FDA

Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia

Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates

Induction immunosuppressive therapies in renal transplantation

Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal

Influence of the exchange and correlation functional on the structure of amorphous InSb and In3SbTe2 compounds.

Influenza in solid organ transplant recipients.

Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns

Invasive fungal infections and antifungal therapies in solid organ transplant recipients.

Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?

Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch

Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients

Managing Risk in Developing Transplant Immunosuppressive Agents: The New Regulatory Environment ⬇️

Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs

Micafungin treatment and eradication of candiduria among hospitalized patients

Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients

Mycophenolate fetal toxicity and risk evaluation and mitigation strategies

Nephrotoxicity of Natural Products

New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines

Pharmacoepidemiology of anemia in kidney transplant recipients

Recommendations for the proper use of nonprescription cough suppressants and expectorants in solid-organ transplant recipients

Risk evaluation and mitigation strategies: a focus on belatacept

Risk evaluation and mitigation strategies: a focus on the mammalian target of rapamycin inhibitors

Risk evaluation and mitigation strategies: a focus on the mycophenolic acid preparations

Understanding alterations in drug handling with aging: a focus on the pharmacokinetics of maintenance immunosuppressants in the elderly

Understanding risk evaluation and mitigation strategies in organ transplantation

Use of polyclonal/monoclonal antibody therapies in transplantation